癌症患者中随机启动IVF周期的IVF特征与黄体分子特征与传统周期无差异
本研究在62例癌症患者中比较随机启动(晚卵泡期20例、中黄体期20例)与传统早卵泡期启动(22例)的IVF周期。结果显示两组在促性腺激素刺激时长(随机启动更长)、卵巢反应、卵母细胞产出、受精率、胚胎发育能力及黄体颗粒细胞的类固醇合成酶表达、促性腺激素受体表达和E2、P4产生上均无显著差异。
要点
- 随机启动IVF周期的促性腺激素刺激时长显著长于传统启动周期。
- 随机启动与传统启动周期在卵巢反应、卵母细胞产出、受精率和第5天囊胚形成率上相当。
- 随机启动周期黄体颗粒细胞的类固醇合成酶表达、促性腺激素受体表达及E2、P4产生与传统周期几乎相同。
核心结论
- 在癌症患者中,随机启动(晚卵泡期和中黄体期)IVF周期的IVF参数和黄体类固醇合成分子特征与传统早卵泡期启动周期完全可比。
研究设计与样本
- 临床转化研究,纳入2017年至2022年间接受IVF以保存生育力的62例癌症患者,其中41例行卵母细胞冷冻、21例行胚胎冷冻,均采用GnRH拮抗剂方案和人绝经期促性腺激素。
- 22例在早卵泡期传统启动作为对照,20例在晚卵泡期启动,20例在中黄体期启动。
- 乳腺癌和子宫内膜癌患者联合使用芳香化酶抑制剂来曲唑与促性腺激素刺激。
- 从取卵时的卵泡穿刺液中回收黄体化颗粒细胞,对每例患者分别进行实验。
主要发现
- 传统启动与随机启动IVF周期患者的基线人口学和IVF特征相似。
- 促性腺激素刺激时长在晚卵泡期和中黄体期启动周期中显著长于传统启动周期。
- 卵巢对促性腺激素刺激的反应、成熟和总卵母细胞产出、受精率及第5天囊胚形成率在传统启动与随机启动周期之间相当。
- 随机启动周期黄体颗粒细胞的活力指数和光镜下形态学特征未见明显差异。
- RT-PCR和免疫印迹分析显示,随机启动周期黄体颗粒细胞的促性腺激素受体、性类固醇合成酶及胆固醇合成/利用酶表达谱和类固醇合成活性与传统启动周期几乎相同。
临床怎么用
- 作者认为,研究结果提供保证:随机启动方案为癌症患者提供与传统IVF同样好的生育力保存前景。
局限性
- 尚不清楚既往癌症药物暴露、不同卵巢病理或不孕病因、既往卵巢手术和/或与癌症同时存在的其他基础疾病是否会导致传统与随机启动刺激方案在IVF参数、黄体功能和生殖结局方面存在差异,因此解读数据和咨询寻求生育力保存的癌症患者时应谨慎。
- 每种刺激方案的患者数量相对较少,且对每例患者的黄体颗粒细胞进行混合分析而非对每个卵泡和卵母细胞单独分析,是本研究的额外局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Are the IVF parameters and the steroidogenic luteal characteristics of random-start IVF cycles different from conventional cycles in cancer patients? SUMMARY ANSWER: No; controlled ovarian stimulation cycles randomly started at late follicular phase (LFP) and luteal phase (LP) are totally comparable to those conventional IVF cycles started at early follicular phase (EFP) in terms of the expression of the enzymes involved in cholesterol utilization and steroid hormone biosynthesis pathways, gonadotropin receptor expression and, estradiol (E2) and progesterone (P4) production in addition to the similarities in ovarian response to gonadotropin stimulation, oocyte yield, fertilization rate and embryo development competency in cancer patients. WHAT IS KNOWN ALREADY: Random start ovarian stimulation protocols are commonly employed for oocyte and embryo freezing for fertility preservation in cancer patients with time constraints who do not have sufficient time to undergo ovarian stimulation initiated conventionally at EFP of the next cycle. No data is available regarding the molecular steroidogenic features of these cycles analyzed together with the clinical IVF characteristics in cancer patients. We aimed to address this question in this study to help understand how similar the random start cycles are to the conventional start ones. STUDY DESIGN, SIZE, DURATION: A clinical translational research study conducted in 62 cancer patients undergoing IVF for fertility preservation between the years 2017 and 2022. PARTICIPANTS/MATERIALS, SETTING, METHODS: Sixty-two patients who were diagnosed with different types of cancer and underwent ovarian stimulation for oocyte (n = 41) and embryo (n = 21) cryopreservation using GnRH antagonist protocol and human menopausal gonadotropins before receiving cancer treatment/surgery were enrolled in the study. For patients with breast cancer and endometrial cancer the aromatase inhibitor letrozole was used with gonadotropin stimulation. Ovarian stimulation was initiated conventionally at EFP in 22 patients and served as control while it was started at LFP in 20, and mid-LP in the other 20 patients. The luteinized granulosa cells (GCs) were recovered from follicular aspirates during oocyte retrieval procedure and used for the experiments separately for each individual patient. The expression of the enzymes involved in sex steroid biosynthesis (StAR, 3β-HSD, Aromatase) and cholesterol synthesis (3-hydroxy 3-methylglutaryl Co-A reductase (HMG-Co-A reductase)), utilization (hormone sensitive lipase (HSL)), and storage (Acetyl-Coenzyme A acetyltransferase 1 (ACAT-1)), and gonadotropin receptor expression status were analyzed using immunoblotting and RT-PCR methods. Laser confocal immunofluorescence imaging was applied to analyze and compare the expression patterns of the steroidogenic enzymes and their relation with mitochondria. In vitro E2 and P4 production by the cells were compared among the groups. MAIN RESULTS AND THE ROLE OF CHANCE: Baseline demographic and IVF characteristics of the patients undergoing the conventional start and random start IVF cycles were similar. Duration of gonadotropin stimulation was significantly longer in LFP and LP start cycles in comparison to the conventional ones. Ovarian response to gonadotropin stimulation, mature and total oocyte yield, fertilization and Day 5 blastulation rates of the embryos were comparable between the conventional versus random start cycles. When the luteal GCs of these random start cycles were analyzed we could not find any gross differences between these cycles in terms of the viability index and gross light microscopic morphologic features. More detailed analysis of the molecular luteal characteristics of the cells using RT-PCR, immunoblotting methods revealed that the expression profiles of the gonadotropin receptors, and the enzymes involved in sex steroid biosynthesis and cholesterol synthesis/utilization, and the steroidogenic activity of the luteal GCs of the random start cycles are almost identical to those of the conventional start cycles. Confocal image analysis demonstrated similar patterns in the signal expression profiles of the steroidogenic enzymes and their co-localization within mitochondria. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: Caution should be exercised when interpreting our data and counseling cancer patients seeking fertility preservation because it is still unclear if previous exposure to cancer drugs, different ovarian pathologies or infertility etiologies, previous ovarian surgery and/or any other underlying diseases that are concomitantly present with cancer may cause a difference between conventional and random start stimulation protocols in terms of IVF parameters, luteal function and reproductive outcome. Relatively low number of patients in each stimulation protocol and pooling of luteal GCs for each patient rather than individual analysis of each follicle and oocyte are additional limitations of our study. WIDER IMPLICATIONS OF THE FINDINGS: Our findings provide reassurance that random start protocol offers cancer patients an equally good prospect of fertility preservation as conventional IVF. STUDY FUNDING/COMPETING INTEREST(S): Funded by the School of Medicine, the Graduate School of Health Sciences of Koc University and Koç University Research Center for Translational Medicine (KUTTAM), equally funded by the Republic of Turkey Ministry of Development Research Infrastructure Support Program. All authors declare no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Esmaeilian Y, Hela F, Bildik G, et al. IVF characteristics and the molecular luteal features of random start IVF cycles are not different from conventional cycles in cancer patients. Hum Reprod. 2023. PMID: 36367834. doi:10.1093/humrep/deac242
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。